P164 The impact of a local, validated structured education programme on anxiety and depression in people with diabetes
Published Date: 14th April 2021
Publication Authors: Narayanan RP, Westall S, Sullivan H, Cardwell J, Cairns J, Gallagher CG, Bujawansa S, McNulty S, Furlong NJ, Hardy KJ
Background
People with type 1 and type 2 diabetes experience greater degrees of anxiety and depression than the general population. The Hospital Anxiety Depression Scale (HADS) can evaluate this. Scores ≥8 on HADS-A (anxiety) or HADS-D (depression) indicate potential cases of anxiety or depression.
Methods
As part of a validated structured education programme, baseline and endpoint measurements of anxiety and depression were measured using HADS. Data from the questionnaires were analysed in Excel with the ‘Analysis ToolPak’.
Results
421 patients completed baseline and endpoint questionnaires. Percentage of type 1 diabetes patients scoring ≥8 in HADS-A went from 41% to 31% and in HADS-D went from 13% to 18%. Percentage of type 2 diabetes patients scoring ≥8 in HADS-A went from 28.9% to 27.6% and in HADS-D went from 19.8% to 18.9%. In type 1 diabetes, mean score for HADS-A went from 6.6 to 6.0 and for HADS-D from 4.4 to 4.0. In type 2 diabetes, mean score for HADS-A went from 5.7 to 5.2 and for HADS-D from 4.7 to 4.4. The differences in means were not statistically significant in either group.
Conclusion
Structured education did not have a statistically significant impact on anxiety or depression. Anxiety and depression are highly prevalent among people with diabetes. In our hospital, we have implemented dedicated psychology input for patients with diabetes. We are developing pathways towards tailored early access to local primary and secondary care mental health and substance misuse services for people with high levels of anxiety or depression.
Narayanan, RP; Westall, SJ; Sullivan, H; Cardwell, J; Cairns, J; Gallagher, C; Bujuwansa, S; McNulty, S; Furlong, N; Hardy, K. (2021). P164 The impact of a local, validated structured education programme on anxiety and depression in people with diabetes. Diabetic Medicine. 38 (S1), 60.